Skip to content
10-Q

Quarterly Report

GEVO, INC. GEVO

0001392380-26-000016

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 243.41M sh
Shares Diluted Q1 2026 · Mar 31, 2026 236.84M sh
Shares Diluted Q1 2026 · Mar 31, 2025 232.03M sh
Capex Q1 2026 · Mar 31, 2026 $8.88M
Capex Q1 2026 · Mar 31, 2025 $5.83M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$21.14M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$24.05M
Long Term Debt Q1 2026 · Mar 31, 2026 $166.75M
Long Term Debt Q1 2026 · Dec 31, 2025 $164.75M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $78.9M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $81.16M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $65.29M
Stockholders Equity Q1 2026 · Mar 31, 2026 $447.75M
Stockholders Equity Q1 2026 · Dec 31, 2025 $466.34M
Stockholders Equity Q1 2026 · Mar 31, 2025 $469.84M
Stockholders Equity Q1 2026 · Dec 31, 2024 $489.49M
Current Liabilities Q1 2026 · Mar 31, 2026 $26.89M
Current Liabilities Q1 2026 · Dec 31, 2025 $78.59M
Total Liabilities Q1 2026 · Mar 31, 2026 $198.8M
Total Liabilities Q1 2026 · Dec 31, 2025 $247.76M
Current Assets Q1 2026 · Mar 31, 2026 $115.87M
Current Assets Q1 2026 · Dec 31, 2025 $143.4M
Total Assets Q1 2026 · Mar 31, 2026 $653.5M
Total Assets Q1 2026 · Dec 31, 2025 $718.93M
Total Assets restated Q1 2026 · Mar 31, 2025 $718.93M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.09
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 −$0.09
Rd Expense Q1 2026 · Mar 31, 2026 $1.5M
Rd Expense Q1 2026 · Mar 31, 2025 $1.05M
Net Income Q1 2026 · Mar 31, 2026 −$21.7M
Net Income Q1 2026 · Mar 31, 2025 −$21.73M
Operating Income Q1 2026 · Mar 31, 2026 −$4.9M
Operating Income Q1 2026 · Mar 31, 2025 −$20.14M
Revenue Q1 2026 · Mar 31, 2026 $42.95M
Revenue Q1 2026 · Mar 31, 2025 $29.11M